Skin Whitening in Myeongdong — Walk-In Korean Brightening Clinic Near Myeongdong Station

Intravenous Glutathione for Skin Lightening

Glutathione (L-gamma-glutamyl-L-cysteinyl-glycine) exerts its depigmenting effect through multiple converging mechanisms at the melanocyte level. First, it directly inhibits tyrosinase activity by chelating copper ions essential for the enzyme’s catalytic function, reducing the oxidation of L-tyrosine to L-DOPA and subsequently L-DOPA to dopaquinone. Second, Glutathione acts as a thiol donor that conjugates with dopaquinone to form 5-S-cysteinylDOPA, which is preferentially metabolized into pheomelanin (light yellow pigment) rather than eumelanin (dark brown pigment), effectively shifting the balance of melanin types in the skin. Third, Glutathione scavenges reactive oxygen species (ROS) that otherwise stimulate melanocyte proliferation and melanogenesis via the p38 MAPK signaling pathway. Intravenous administration achieves plasma Glutathione concentrations 10-20 times higher than oral supplementation due to the first-pass hepatic metabolism that degrades ingested Glutathione. Sonthalia et al. (2018) reviewed the evidence for injectable Glutathione in skin lightening, finding consistent melanin index reduction across multiple clinical studies when delivered at 600-1200mg doses weekly.

Picosecond Laser Selective Photomechanics for Pigmentation

The PicoSure 755nm picosecond laser exploits selective photothermolysis at ultra-short pulse durations (750 picoseconds) that are shorter than the thermal relaxation time of melanosomes, ensuring energy confinement within melanin particles. This creates photoacoustic shock waves that mechanically fragment melanin granules into nano-particles averaging 10-30nm in diameter — small enough for efficient phagocytosis by dermal macrophages and subsequent lymphatic clearance. The Focus Lens Array further concentrates energy into microscopic focal zones, inducing Laser-Induced Optical Breakdown (LIOB) that creates vacuoles in the dermal-epidermal junction without bulk tissue heating. Tanghetti (2016) demonstrated that picosecond laser with diffractive lens array produced significant improvement in dyschromia, photodamage, and skin quality in a prospective clinical trial involving 20 subjects with Fitzpatrick skin types II-V, with improvements maintained at 6-month follow-up and no cases of post-inflammatory hyperpigmentation. This photomechanical selectivity is the fundamental advantage over nanosecond Q-switched lasers for skin whitening in Asian patients.

Combination Protocol Optimization

The theoretical basis for combining systemic Glutathione with topical/laser melanin clearance rests on addressing melanogenesis at multiple points in the pathway simultaneously. Glutathione inhibits melanin synthesis upstream (tyrosinase inhibition + melanin type switching), while picosecond laser removes existing melanin downstream (mechanical fragmentation + lymphatic clearance). This bidirectional approach prevents new melanin formation while actively clearing the melanin reservoir, producing faster and more durable whitening than either treatment alone. Handog et al. (2016) published a comprehensive review of combined modality skin lightening approaches, concluding that multi-target protocols achieve superior outcomes compared to single-agent treatments, with the combination of antioxidant support and laser intervention representing the most evidence-based approach.

References: Sonthalia S et al. J Clin Aesthet Dermatol. 2018;11(1):13-17. doi:10.1111/jocd.12528 | Tanghetti EA. J Cosmet Laser Ther. 2016;18(6):307-312. doi:10.1080/14764172.2016.1197404 | Handog EB et al. Dermatol Ther. 2016;6(2):165-178. doi:10.1007/s13555-016-0110-1